Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.
暂无分享,去创建一个
Alun Thomas | Sue Healey | John L Hopper | Irene L Andrulis | Georgia Chenevix-Trench | Catherine Voegele | Janet Hall | David C Whiteman | Melissa C Southey | Peter J Oefner | Florence Le Calvez-Kelm | Sean V Tavtigian | P. Oefner | J. Hopper | E. John | M. Southey | S. Sangrajrang | G. Chenevix-Trench | S. Tavtigian | I. Andrulis | Alun Thomas | D. Whiteman | G. Byrnes | M. Hashibe | P. Webb | F. Lesueur | S. Healey | S. Chuang | Graham B Byrnes | M. Vallée | F. Le Calvez-Kelm | C. Voegele | Mia Hashibe | Penelope M Webb | Esther M John | Fabienne Lesueur | Suleeporn Sangrajrang | Sandrine McKay-Chopin | Davit Babikyan | Anne Hartmann | Shu-Chun Chuang | Nathalie Forey | Corinna Feuchtinger | Lydie Gioia | Barbara Herte | Maxime P Vallée | S. Mckay-Chopin | D. Babikyan | N. Forey | Janet Hall | A. Hartmann | Corinna Feuchtinger | L. Gioia | Barbara Herte | Nathalie Forey | Sandrine Mckay-Chopin | Shu-Chun Chuang
[1] R. Stock,et al. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. , 2002, International journal of radiation oncology, biology, physics.
[2] G. Kay,et al. Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype. , 2001, Cancer research.
[3] D. Cox,et al. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. , 2003, Cancer research.
[4] O. Peralta,et al. Association of common ATM variants with familial breast cancer in a South American population , 2008, BMC Cancer.
[5] T. Buchholz,et al. A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls , 2004, Cancer.
[6] S. Seal,et al. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. , 1998, British Journal of Cancer.
[7] L. Cantley,et al. DNA Damage-induced Association of ATM with Its Target Proteins Requires a Protein Interaction Domain in the N Terminus of ATM* , 2005, Journal of Biological Chemistry.
[8] R. Darnell,et al. ATM binds to β-adaptin in cytoplasmic vesicles , 1998 .
[9] J. Klijn,et al. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. , 2000, American journal of human genetics.
[10] M. Lovett,et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.
[11] M. Jung,et al. ATM missense mutations are frequent in patients with breast cancer. , 2003, Cancer genetics and cytogenetics.
[12] K. Isselbacher,et al. Heterozygous ATM mutations do not contribute to early onset of breast cancer , 1997, Nature Genetics.
[13] S. Henikoff,et al. Accounting for human polymorphisms predicted to affect protein function. , 2002, Genome research.
[14] D. Gotley,et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus , 2007, Gut.
[15] R. Darnell,et al. ATM binds to beta-adaptin in cytoplasmic vesicles. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] S. Tavtigian,et al. In silico analysis of missense substitutions using sequence‐alignment based methods , 2008, Human mutation.
[17] R. Eeles,et al. Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation. , 2006, Cancer research.
[18] W. K. Alfred Yung,et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.
[19] Yoichi Taya,et al. ATM associates with and phosphorylates p53: mapping the region of interaction , 1999, Nature Genetics.
[20] A. Tward,et al. Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. , 1999, Molecular genetics and metabolism.
[21] Sara G. Becker-Catania,et al. Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity. , 2000, Molecular genetics and metabolism.
[22] J. Rashbass. Online Mendelian Inheritance in Man. , 1995, Trends in genetics : TIG.
[23] Sivakumar Gowrisankar,et al. Pattern of sequence variation across 213 environmental response genes. , 2004, Genome research.
[24] E. Ostrander,et al. Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history , 2001, Cancer.
[25] S. Scott,et al. Functional and computational assessment of missense variants in the ataxia‐telangiectasia mutated (ATM) gene: mutations with increased cancer risk , 2009, Human mutation.
[26] Carl T Wittwer,et al. Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. , 2004, Clinical chemistry.
[27] Tú Nguyen-Dumont,et al. Description and validation of high‐throughput simultaneous genotyping and mutation scanning by high‐resolution melting curve analysis , 2009, Human mutation.
[28] J. Sambrook,et al. Dominant negative ATM mutations in breast cancer families. , 2002, Journal of the National Cancer Institute.
[29] S. Sanjosé,et al. ATM germline mutations in Spanish early‐onset breast cancer patients negative for BRCA1/BRCA2 mutations , 2008, Clinical genetics.
[30] T. Dörk,et al. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. , 2001, Cancer research.
[31] A. Spurdle,et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results , 2008, Human mutation.
[32] R. Winqvist,et al. Association of common ATM polymorphism with bilateral breast cancer , 2005, International journal of cancer.
[33] J. Bond,et al. Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants , 2003, Oncogene.
[34] J. Kere,et al. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer. , 2006, Carcinogenesis.
[35] C. Croce,et al. ATM mutations in cancer families. , 1996, Cancer research.
[36] R. Stock,et al. Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high‐performance liquid chromatography , 2001, Environmental and molecular mutagenesis.
[37] David Haussler,et al. Improved splice site detection in Genie , 1997, RECOMB '97.
[38] A. Rosenthal,et al. Clinical Investigation , 2003, Advances in Experimental Medicine and Biology.
[39] Iain M. Wallace,et al. M-Coffee: combining multiple sequence alignment methods with T-Coffee , 2006, Nucleic acids research.
[40] F. Couch,et al. Assessment of functional effects of unclassified genetic variants , 2008, Human mutation.
[41] A. Børresen-Dale,et al. Designing and implementing quality control for multi‐center screening of mutations in the ATM gene among women with breast cancer , 2003, Human mutation.
[42] N. Rahman,et al. A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO , 2004, Journal of Medical Genetics.
[43] A. Zharkikh,et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral , 2005, Journal of Medical Genetics.
[44] P. Oefner,et al. Contributions of ATM mutations to familial breast and ovarian cancer. , 2003, Cancer research.
[45] R. W. Davis,et al. Global analysis of ATM polymorphism reveals significant functional constraint. , 2001, American journal of human genetics.
[46] Y. Shiloh,et al. Interaction between ATM protein and c-Abl in response to DNA damage , 1997, Nature.
[47] Allen Chong,et al. Discovery of estrogen receptor α target genes and response elements in breast tumor cells , 2004, Genome Biology.
[48] John L Hopper,et al. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource , 2006, Breast Cancer Research.
[49] Norman Boyd,et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer , 2004, Breast Cancer Research.
[50] Steven Henikoff,et al. SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..
[51] P. Dundr,et al. Contribution of mutations in ATM to breast cancer development in the Czech population. , 2008, Oncology reports.
[52] J. Klijn,et al. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study , 2007, Breast Cancer Research.
[53] Xiaofeng Jiang,et al. The FATC Domains of PIKK Proteins Are Functionally Equivalent and Participate in the Tip60-dependent Activation of DNA-PKcs and ATM* , 2006, Journal of Biological Chemistry.
[54] A. Børresen-Dale,et al. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. , 2008, Cancer research.
[55] J. Boyd,et al. Hereditary breast cancer. , 2001, Current problems in surgery.
[56] J. Bernstein,et al. ATM heterozygosity and breast cancer: screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based assay , 2000, Breast Cancer Research and Treatment.
[57] P. Brennan,et al. The XRCC3 Thr241Met polymorphism and breast cancer risk: a case–control study in a Thai population , 2007, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[58] K. Gelmon,et al. Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer , 1999, British Journal of Cancer.
[59] Colin N A Palmer,et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema , 2007, Nature Genetics.
[60] H. Bonnefoi,et al. Constitutional alterations of the ATM gene in early-onset sporadic breast cancer , 2000, Breast Cancer Research.
[61] Nazneen Rahman,et al. The emerging landscape of breast cancer susceptibility , 2007, Nature Genetics.
[62] Alun Thomas,et al. A Laboratory Information Management System (LIMS) for a high throughput genetic platform aimed at candidate gene mutation screening , 2007, Bioinform..
[63] K. Isselbacher,et al. Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor , 2000, Genes, chromosomes & cancer.
[64] J. Satagopan,et al. Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[65] J. Stephens,et al. The structure of common genetic variation in United States populations. , 2007, American journal of human genetics.
[66] T. Paull,et al. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks , 2007, Oncogene.
[67] S. Leal,et al. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. , 2008, American journal of human genetics.
[68] A. Broeks,et al. The spectrum of ATM missense variants and their contribution to contralateral breast cancer , 2007, Breast Cancer Research and Treatment.
[69] A. Causse,et al. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases , 2002, Genes, chromosomes & cancer.
[70] Alun Thomas,et al. Classification of rare missense substitutions, using risk surfaces, with genetic‐ and molecular‐epidemiology applications , 2008, Human mutation.
[71] M. James,et al. The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. , 1996, Cancer research.
[72] A. Sidow,et al. Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. , 2005, Genome research.
[73] J. E. Rhoads,et al. Accomplishments in cancer research. 1986 , 1987 .
[74] D. Purdie,et al. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer , 2002, Nature Genetics.
[75] M. Lavin,et al. Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[76] Lester L. Peters,et al. Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.
[77] S. Seal,et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene , 2007, Nature Genetics.
[78] T. Dörk,et al. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer , 2009, Breast Cancer Research and Treatment.
[79] A. Lindblom,et al. The role of ataxia-telangiectasia heterozygotes in familial breast cancer. , 1998, Cancer research.
[80] C. Mathew,et al. Identification of germline missense mutations and rare allelic variants in the ATM gene in early‐onset breast cancer , 1999, Genes, chromosomes & cancer.
[81] R. Stock,et al. Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy. , 2007, International journal of radiation oncology, biology, physics.
[82] M. Moraga,et al. ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences? , 2007, Breast Cancer Research and Treatment.
[83] P. Oefner,et al. Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling , 2006, Genes, chromosomes & cancer.
[84] Douglas Easton,et al. The Genetic Epidemiology of Breast Cancer Genes , 2004, Journal of Mammary Gland Biology and Neoplasia.
[85] M. Swift,et al. Breast and other cancers in families with ataxia-telangiectasia. , 1987, The New England journal of medicine.
[86] S. Tavtigian,et al. Molecular Diagnostics: Methods and Limitations , 2007 .
[87] Nazneen Rahman,et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles , 2006, Nature Genetics.
[88] Douglas F Easton,et al. Genetic evidence and integration of various data sources for classifying uncertain variants into a single model , 2008, Human mutation.
[89] Andrew Menzies,et al. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation , 2009, Nature Genetics.
[90] S. Fox,et al. Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis , 2008, BMC Cancer.
[91] Y. Shiloh,et al. Genomic Organization of the ATM gene. , 1996, Genomics.
[92] T. Dörk,et al. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[93] Nazneen Rahman,et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles , 2006, Nature Genetics.
[94] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.